| PRD_000332 | Name: | Cbz-Asp-Glu-Val-AAsp-CHCH-CON(CH3)CH2Ph | Formula: | C36 H46 N6 O13 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_001184 | Name: | Dimethyl FK228 | Formula: | C26 H42 N4 O6 S2 | Description: | DIMETHYL FK228 IS THE REDUCED AND MODIFIED FORM OF ROMIDEPSIN. THE DISULFIDE INTRAMOLECULAR LINKAGE OF ROMIDEPSIN IS BROKEN, AND BOTH SULFHYDRYL GROUPS ARE METHYLATED. | Definition date: | 2014-03-05 | Last modified: | 2023-11-03 |
|
| PRD_001198 | Name: |
(3aR,5aS,8S,10aS)-1-[(3S,6R,8aS)-1'-[(2S)-2-acetamido-3-(2-chlorophenyl)propanoyl]-5-oxidanylidene-spiro[1,2,3,8a-tetrahydroindolizine-6,2'-pyrrolidine]-3-yl]carbonyl-10-oxidanylidene-2,3,3a,5a,8,10a-hexahydrodipyrrolo[3,2-b:3',1'-f]azepine-8-carboxylic acid | Formula: | C35 H38 Cl N5 O7 | Definition date: | 2014-10-15 | Last modified: | 2023-11-03 |
|
| PRD_001233 | Name: | cyclic-tris-phenylselenazole | Formula: | C36 H30 N6 O3 Se3 | Definition date: | 2015-03-04 | Last modified: | 2023-11-03 |
|
| PRD_001234 | Name: | cyclic-tris-leucylselenazole | Formula: | C27 H36 N6 O3 Se3 | Definition date: | 2015-03-04 | Last modified: | 2023-11-03 |
|
| PRD_001235 | Name: | cyclic-tris-valinylselenazole | Formula: | C24 H30 N6 O3 Se3 | Definition date: | 2015-03-04 | Last modified: | 2023-11-03 |
|
| PRD_001236 | Name: | cyclic-tris-alanylselenazole | Formula: | C18 H18 N6 O3 Se3 | Definition date: | 2015-03-04 | Last modified: | 2023-11-03 |
|
| PRD_001255 | Name: | Promothiocin A | Formula: | C36 H47 N11 O8 S2 | Definition date: | 2014-12-10 | Last modified: | 2023-11-03 |
|
| PRD_000561 | Name: | FR901277 | Formula: | C47 H63 N9 O13 | Definition date: | 2020-08-12 | Last modified: | 2023-11-03 |
|
| PRD_002111 | Name: | 3,5-difluoro-Nalpha-[(2E,5S)-5-methylhept-2-enoyl]-N-[(2S,6aS,12S,13R,15aS,21S,23aS)-2,13,21-trimethyl-6,11,15,20,23-pentaoxooctadecahydro-2H,6H,11H,15H-pyrido[2,1-i]dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13]oxatetraazacyclohexadecin-12-yl]-L-phenylalaninamide | Formula: | C41 H56 F2 N6 O8 | Definition date: | 2014-10-08 | Last modified: | 2023-11-03 |
|
| PRD_002132 | Name: | (10S,13S,16S,19S)-16-benzyl-12-(N-methyl-L-alanyl-L-valyl)-3,14,17-trioxo-2,7,8,9,12,15,18-heptaazatetracyclo[19.2.2.1~6,9~.1~10,13~]heptacosa-1(23),6(27),7,21,24-pentaene-19-carboxylic acid | Formula: | C37 H47 N9 O7 | Definition date: | 2015-03-04 | Last modified: | 2023-11-03 |
|
| PRD_002204 | Formula: | C21 H34 N4 O7 | Definition date: | 2016-07-27 | Last modified: | 2023-11-03 |
|
| PRD_000641 | Name: | (10R,20R,23R)-10-(4-aminobutyl)-1-[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]-20,23-bis(3-carbamimidamidopropyl)-1,8,11,18,21-pentaoxo-2,9,12,19,22-pentaazatetracosan-24-amide | Formula: | C40 H70 N18 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_000642 | Name: | (10R,20R,23R)-1-[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]-20,23-bis(3-carbamimidamido
propyl)-10-methyl-1,8,11,18,21-pentaoxo-2,9,12,19,22-pentaazatetracosan-24-amide | Formula: | C37 H63 N17 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_000645 | Name: | (2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-N-(6-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-carbamoylbutyl]carbamoyl}butyl]amino}-6-oxohexyl)-3,4-dihydroxytetrahydrofuran-2-carboxamide | Formula: | C28 H47 N15 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_002282 | Name: | (3S,6S,9S,15aR)-6,9-dibenzyl-3-{6,6-dihydroxy-6-[(2S)-oxiran-2-yl]hexyl}octahydro-2H-pyrido[1,2-a][1,4,7,10]tetraazacyclododecine-1,4,7,10(3H,12H)-tetrone | Formula: | C34 H44 N4 O7 | Definition date: | 2017-09-13 | Last modified: | 2023-11-03 |
|
| PRD_000672 | Name: | CBZ-ASP-GLU-VAL-azaASP-EP-CO-NH-CH2PH | Formula: | C35 H44 N6 O14 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_000673 | Name: | CBZ-ASP-GLU-VAL-azaASP-EP-COO-CH2PH | Formula: | C35 H43 N5 O15 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_000674 | Name: | CBZ-ASP-GLU-VAL-azaASP-EP-CO-N(CH2PH)2 | Formula: | C42 H50 N6 O14 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_000727 | Name: | PYOVERDIN G173 Fe Complex | Formula: | C49 H66 Fe N13 O21 | Description: | IN IRON-DEFICIENT CONDITIONS, PSEUDOMONAS
AERUGINOSA SECRETES A MAJOR FLUORESCENT
SIDEROPHORE NAMED PYOVERDIN (PVD),
WHICH AFTER CHELATING IRON(III) IS TRANSPORTED
BACK INTO THE CELL VIA ITS OUTER MEMBRANE RECEPTOR
FPVA. FPVA IS A TONB-DEPENDENT TRANSPORT PROTEIN
AND HAS THE ABILITY TO BIND PVD IN ITS APO-
OR IRON-LOADED FORM. | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_000770 | Name: | (5S, 8R, 11S)-14-[4-(BENZYLOXY)-4-OXOBUTANOYL]-8-(2-CARBOXYETHYL)-5-(CARBOXYMETHYL)-11-
(1-METHYLETHYL)-3,6,9,12-TETRAOXO-1-PHENYL-2-OXA-4,7,10,13,14-PENTAAZAHEXADECAN-16-OIC ACID | Formula: | C35 H43 N5 O14 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_002350 | Name: | INHIBITOR ARC-1415 | Formula: | C55 H106 N30 O8 | Definition date: | 2021-08-04 | Last modified: | 2023-11-03 |
|
| PRD_000785 | Name: | Largazole | Formula: | C21 H29 N4 O4 S3 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_000814 | Name: | N-{[(3R,4R,7S,10R,11R)-3-ethyl-11,15-dihydroxy-3-methyl-10-(methylamino)-6,9-dioxo-7-(propan-2-yl)-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),12,14-trien-4-yl]carbonyl}glycine | Formula: | C23 H34 N4 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_000142 | Name: | Cyclosporin A | Formula: | C62 H111 N11 O12 | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|